ALM.L Share News (ALM)

Allied Minds raises £5m from Neil Woodford for prostate cancer technology

(ShareCast News) - Star UK fund manager Neil Woodford has bought £5m of new shares in Allied Minds subsidiary Precision Biopsy. Woodford Investment Management, which is already a substantial shareholder in FTSE 250-listed Allied Minds purchased 0.95m preference shares in Precision Biopsy. Having de

Allied Minds partners with GE Ventures to commercialise emerging tech

(ShareCast News) - FTSE 250 intellectual property company Allied Minds partnered with General Electric's venture capital subsidiary to commercialise next generation technologies. Allied Minds and GE Ventures agreed to invest in new and existing technologies from each of their innovation pipelines.

Allied Minds losses increase but focus remains on future potential

(ShareCast News) - Allied Minds, the university and government technology commercialisation specialist, reported an increased loss, smaller revenue and flat value of its investment assets over the first half of the year. However, the company remains more firmly focused on investing in its various as

Allied Minds secures debt funding and raises funds for drug programme

(ShareCast News) - Venture capital-style investor Allied Minds has arranged a one-year debt facility Silicon Valley Bank in the US, while its drug discovery subsidiary has raised funds for its leading project from institutional investors. Secured over certain group assets, the $20m one-year facility

Allied Minds investment SciFluor gets nod from FDA

(ShareCast News) - Life science and technology investor Allied Minds announced on Monday that one of its key subsidiaries, SciFluor Life Sciences, has achieved the necessary scientific and regulatory milestones to enter clinical trials. The FTSE 250 company said SciFluor's Investigational New Drug a

DIRECTOR DEALINGS: Allied Minds COO Marc Eichenberger Sells Shares

FTSE 250 movers: Phoenix Group firms on AXA Wealth deal

(ShareCast News) - FTSE 250 was marginally firmer in late afternoon trade as UK traders wound down ahead of a long weekend, with few of today's in-the-news mid-cap stocks figuring among that index's top-10 risers. Shares in Phoenix Group Holdings were ahead as it agreed with AXA UK to buy AXA Wealth

Allied Minds announces successful completion of feasibility programme

(ShareCast News) - Allied Minds' partnership with Bristol-Myers Squibb (BMS), Allied-Bristol Life Sciences, has successfully completed the drug candidate feasibility programme ABLS II and has approved up to $15m to fund further development of the lead optimisation programme. ABLS II is seeking to de

Allied Minds Approves USD15 Million Funding For Allied-Bristol

AGM, EGM Calendar - Week Ahead

DIRECTOR DEALINGS: Allied Minds COO Sells 49,242 Shares

WINNERS & LOSERS SUMMARY: Cobham Crushed On Weak Profit, Rights Issue

Allied Minds secures £55m funding for up to ten new drugs

(ShareCast News) - Science and technology development and commercialisation company Allied Minds announced a fresh $80m (£55m) of investment commitments on Tuesday, received through its newly-formed subsidiary ABLS Capital. The FTSE 250 firm said the funding would allow up to ten potential lead opti

Allied Minds Secures USD80 Million Commitments For Drug Development

FTSE 250 movers: Ted Baker boosted as strike threat hits Wood Group

(ShareCast News) - The FTSE 250 remained in the black in afternoon trading on Monday, though some stocks were under the pump as crude and copper prices fell. Ted Baker was one of the leading risers, after analysts at Jefferies upgraded the stock to 'buy' from 'hold', though they did cut the price ta